Illustration of a hand with multiple treatment paths, symbolizing the varying approaches to carpal tunnel syndrome care.

Carpal Tunnel Syndrome: Why Nonsurgical Treatments Vary So Much

Lena Voss monogram
Lena Voss in Health & Wellness October 2026 • 4 min read.

"Navigating the maze of carpal tunnel syndrome treatments: Why do different clinics offer different options, and what does it mean for you?"


Millions of people experience the discomfort and disruption of carpal tunnel syndrome (CTS) each year. Characterized by pain, numbness, and tingling in the hand and arm, CTS often leads to difficulties in daily activities and work. While surgery offers a well-known solution, many individuals first explore nonsurgical options. These include physical therapy, medication, and lifestyle adjustments, but a new study reveals some significant variations in how these treatments are offered.

Recent research has brought to light the significant differences in how various healthcare facilities approach the treatment of carpal tunnel syndrome. This article delves into the findings of a major study examining these variations within a large integrated healthcare system, offering insights into why these differences exist and what they might mean for patients.

Understanding these variations is crucial for anyone dealing with CTS. By examining the different approaches, we can gain a clearer picture of what effective treatment looks like and make more informed decisions about our own healthcare. This article aims to clarify these complexities and provide you with a better understanding of the treatment landscape.

AI Search Multiple angles on this topic

Prevalence Estimates Vary

Reported estimates of carpal tunnel syndrome vary substantially by source and definition. Gitnux reports that the condition affects 10–15% of people over a lifetime, while another Gitnux report places clinically confirmed adult prevalence at about 3.8%. Wifitalents reports prevalence of 4% to 6%, a lifetime reach of 2% to 3.5%, and annual incidence of 99 per 100,000 person-years. These differences show why the measured impact depends on the population and diagnostic criteria used.

Surgery and Conservative Care

Treatment options for carpal tunnel syndrome are generally divided into surgical and conservative approaches. Conservative care is used to manage symptoms without directly releasing the transverse carpal ligament, whereas surgery relieves pressure on the median nerve by severing that ligament. The 2024 AAOS guideline addresses diagnosis and treatment in adults with complaints attributable to carpal tunnel syndrome. However, one review notes that there is no universally accepted approach to treating all patients with carpal tunnel syndrome.

From Observation to Compression Theory

Patients who appear to have had carpal tunnel syndrome are depicted in surgical literature dating back at least to the mid-1800s. Although carpal tunnel syndrome is now recognized as a median nerve compression disorder at the wrist, the JAMA Neurology history notes that nearly 100 years passed between the initial observations and acceptance of that pathophysiology. This history illustrates how clinical descriptions preceded a widely accepted explanation of the disease mechanism. Later treatment evolution included the development of conservative interventions such as splinting.

The Study: Unveiling the Variability in CTS Care

Illustration of a hand with multiple treatment paths, symbolizing the varying approaches to carpal tunnel syndrome care.

A study published in the Journal of Hand Surgery examined the treatment patterns for carpal tunnel syndrome within the Veterans Health Administration (VHA), a large, integrated healthcare system. The researchers analyzed data from thousands of patients diagnosed with CTS in 2013, focusing on the use of both surgical and nonsurgical treatments. The goal was to understand how the use of various services, such as physical therapy, medication, and diagnostic tests, differed across different facilities within the VHA.

The study found that a considerable range of care exists for CTS patients, especially when considering nonsurgical services. The researchers assessed the use of five different types of services: electrodiagnostic studies (EDS), imaging, steroid injections, oral steroids, and therapeutic modalities. The study compared treatment approaches both before and after any potential surgery. This comparison revealed how treatment strategies changed for those who underwent surgery and those who opted for nonsurgical care.

  • Electrodiagnostic Studies (EDS): These tests, often used to confirm a CTS diagnosis, showed significant variability in usage, ranging from 0% to 100% between different facilities.
  • Therapeutic Modalities: Services like physical therapy and occupational therapy also demonstrated a wide range of use, varying from 0% to 93% across different facilities.
  • Other Treatments: The use of imaging, steroid injections, and oral steroids also varied, although to a lesser degree.
AI Search Multiple angles on this topic

Research on Classification and Treatment

Recent research is examining both surgical advances and changing nonsurgical practice. A 2026 paper describes surgical decompression as the definitive treatment for refractory or severe cases and focuses on the evolution of surgical management. A separate study surveys Australian hand therapists about noninvasive management and treatment patterns over a 15-year period. Another 2026 article identifies classification based on clinical signs and symptoms as an area for future research that could help therapists decide between nonsurgical management and surgical referral.

When Release Does Not Resolve Symptoms

Carpal tunnel release is described as a routine and effective treatment, but dissatisfied patients can still present diagnostic and therapeutic challenges. The literature on unsuccessful release discusses possible reasons for poor results, the workup that follows, and evidence concerning revision surgery. These cases matter because persistent symptoms after surgery may require clinicians to reconsider the diagnosis or determine why the initial procedure did not provide the expected result. The AAOS guideline provides a broader evidence-based framework for adult diagnosis and treatment.

Surgery Compared With Splinting

Evidence comparing surgery with nonsurgical care does not make the choice identical for every patient. The Cochrane review reports that surgery probably produces a higher rate of clinical improvement than splinting after 6 to 12 months, while the evidence about which treatment causes fewer harmful effects remains uncertain. The underlying review also states that surgery is generally considered when symptoms persist despite nonsurgical treatment, but that it remains unclear whether surgery produces a better outcome in every comparison. These findings support individualized decisions rather than a single universal treatment path.

These findings highlight a critical issue: patients at one facility might receive a very different set of treatments compared to those at another. This lack of standardization raises questions about the efficiency and effectiveness of care. It also prompts a deeper look at how these variations might impact patient outcomes, such as recovery time and the overall quality of life.

Making Informed Choices in CTS Treatment

The variations in carpal tunnel syndrome treatments underscore the importance of staying informed and engaged in your own healthcare journey. By understanding the range of treatment options and the potential differences in care, you can have more productive conversations with your healthcare providers. This knowledge empowers you to make choices that align with your specific needs and circumstances, ultimately leading to better outcomes and improved quality of life. Remember to always seek advice from healthcare professionals.

AI Search Multiple angles on this topic

Evidence-Based Individualization

Clinical practice guidelines for carpal tunnel syndrome are built from systematic reviews of published diagnostic and treatment studies in adults. The condition results from median nerve compression beneath the transverse carpal ligament and can produce pain, numbness, tingling, and weakness in the hand. A systematic review notes that chronic progressive disease lasting at least three months is the most common course, although carpal tunnel syndrome can also be acute. Together, these sources support matching treatment decisions to the clinical presentation rather than treating every case the same way.

Technology and Market Expansion

Proposed areas of advancement include ultrasound-guided release, endoscopic surgery, and artificial-intelligence diagnostics. One market report values the carpal tunnel syndrome treatment market at 4,300 USD million in 2024 and projects growth to 6.8 billion USD by 2035, with an expected 4.2% compound annual growth rate from 2026 through 2035. These figures are projections rather than clinical outcomes, but they indicate commercial interest in new diagnostic and treatment technologies. Future development is therefore likely to combine procedural innovation with changing clinical practice.

Severity and Surgical Decisions Differ

Carpal tunnel syndrome is common and treatable, but the Lancet source reports that grading severity and deciding when to recommend surgery remain challenging. It also states that these decisions vary across the world. For mild cases, nonsurgical treatment is described as the standard for initial care. This variation helps explain why treatment pathways can differ even when clinicians are addressing the same diagnosis.

Real-World Outcomes and Access

A multicenter registry study reported one-year clinical outcomes for carpal tunnel release performed with ultrasound guidance in a large, real-world patient population. This type of evidence evaluates the procedure beyond tightly controlled trial settings. A 2025 research summary also highlights artificial-intelligence diagnostics, incisionless surgeries, and nonsurgical innovations as developments intended to transform patient care. The practical significance of these advances will depend on how reliably they improve diagnosis, recovery, and treatment choices for people in routine care.

What treatment variation can mean for care

In a separate analysis of presurgical care, repeat testing, multiple nonsurgical treatments, and referrals outside the VA were associated with greater delay and resource use. That association does not establish that these processes caused delays or that they produced better or worse health outcomes.[1] [2]

The evidence also points to uncertainty about how to organize nonsurgical care: the effectiveness of several modalities is debated, and clear guidance on treatment duration, number of modalities, and transition to surgery is lacking.[3]

How treatment choices and care pathways compare

A separate VA analysis examined presurgical quality and utilization among patients who went on to release; its facility-level results show that delay was not uniform. These findings concern the route to surgery, rather than the effectiveness of nonsurgical treatment itself.[1]

What remains unresolved in CTS care

  • Do differences in nonsurgical service use reflect appropriate tailoring to patients, or overuse and underuse? The facility-level patterns raise that distinction but do not resolve it.[4]
  • Which nonsurgical strategy, including its duration and number of modalities, best supports a timely transition to surgery when needed? Current guidance on those choices is described as unclear.[1] [3]

Questions about treatment evidence

Do steroid injections always prevent surgery?

No. They are commonly used as an initial treatment, but their benefit is generally short term, and many patients later receive carpal tunnel release.[5]

Carpal tunnel release
A surgical treatment for carpal tunnel syndrome.[6]

Sources

  1. Carpal Tunnel Syndrome as a Test Case for Value Assessment During the Presurgical Period (Medical Care, 2022)
  2. Patient Experience of Presurgical Care for Carpal Tunnel Syndrome Across Treatment Sites in the Veterans Affairs Health System: A Qualitative Analysis (Journal of Hand Surgery Global Online, 2025)
  3. Nonsurgical Treatment of Carpal Tunnel Syndrome: A Survey of Hand Surgeons (pmc.ncbi.nlm.nih.gov)
  4. Variation in Nonsurgical Services for Carpal Tunnel Syndrome Across a Large Integrated Health Care System. (doi.org, 2019)
  5. Predictors and Variation in Steroid Injection Use for Carpal Tunnel Syndrome from a Multicenter Quality Collaborative (Plastic & Reconstructive Surgery, 2023)
  6. Simultaneous Bilateral or Unilateral Carpal Tunnel Release? (Journal of Bone and Joint Surgery, 2014)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.jhsa.2018.11.002, Alternate LINK

Title: Variation In Nonsurgical Services For Carpal Tunnel Syndrome Across A Large Integrated Health Care System

Subject: Orthopedics and Sports Medicine

Journal: The Journal of Hand Surgery

Publisher: Elsevier BV

Authors: Erika D. Sears, Esther L. Meerwijk, Eric M. Schmidt, Eve A. Kerr, Kevin C. Chung, Robin N. Kamal, Alex H.S. Harris

Published: 2019-02-01

Everything You Need To Know

1

What nonsurgical treatments are commonly used for carpal tunnel syndrome (CTS), and why is there so much variation in their application?

Common nonsurgical treatments for carpal tunnel syndrome (CTS) include physical therapy, medication, and lifestyle adjustments. The variation in their application stems from a lack of standardization across different healthcare facilities, as highlighted by a study in the *Journal of Hand Surgery*. The study revealed significant differences in the use of electrodiagnostic studies (EDS), therapeutic modalities, steroid injections, oral steroids, and imaging within the Veterans Health Administration (VHA). This variation suggests that patients may receive different care based on the facility they visit, impacting treatment effectiveness and patient outcomes. The study did not, however, explore the specific patient characteristics or provider preferences that might also contribute to these variations. Furthermore, long-term efficacy of each treatment type was not specifically addressed.

2

The *Journal of Hand Surgery* study mentioned electrodiagnostic studies (EDS) and therapeutic modalities. What do these entail, and how did their use vary in the study?

Electrodiagnostic studies (EDS) are tests used to confirm a diagnosis of carpal tunnel syndrome (CTS). Therapeutic modalities encompass services like physical and occupational therapy. The study revealed a wide range of use for both. EDS usage varied from 0% to 100% across different facilities, while therapeutic modalities varied from 0% to 93%. This means that at some facilities, every patient received EDS, while at others, none did. A similar disparity existed for therapeutic modalities. The study did not investigate the reasons behind these variations, such as differences in staffing, equipment availability, or local protocols. Understanding these underlying factors would provide a more complete picture of CTS treatment.

3

What are the implications of the wide variations in carpal tunnel syndrome (CTS) treatments observed in the *Journal of Hand Surgery* study?

The wide variations in carpal tunnel syndrome (CTS) treatments have several implications. Firstly, patients may receive significantly different care depending on where they seek treatment, potentially affecting their recovery time and overall quality of life. The lack of standardization raises concerns about the efficiency and effectiveness of care. It also suggests a need for more consistent guidelines and protocols for CTS treatment across different healthcare facilities. Further investigation is required to determine how these variations impact long-term patient outcomes and healthcare costs. The study did not assess the influence of socioeconomic factors or patient preferences on treatment choices.

4

Besides electrodiagnostic studies (EDS) and therapeutic modalities, what other treatments for carpal tunnel syndrome (CTS) were assessed in the *Journal of Hand Surgery* study, and how did their use vary?

In addition to electrodiagnostic studies (EDS) and therapeutic modalities, the *Journal of Hand Surgery* study assessed the use of imaging, steroid injections, and oral steroids for carpal tunnel syndrome (CTS) treatment. While the use of these treatments also varied, the degree of variation was less significant compared to EDS and therapeutic modalities. This suggests that while disparities exist across various treatment approaches, some treatments are applied more consistently than others. The study did not explore the potential reasons for these differences in consistency, such as the availability of specific medications or the preferences of individual healthcare providers. Also, the study did not look at alternative therapies like acupuncture or chiropractic care.

5

How can patients make more informed choices about their carpal tunnel syndrome (CTS) treatment given the variability highlighted in the *Journal of Hand Surgery* study?

Given the variability in carpal tunnel syndrome (CTS) treatments, patients should actively engage in their healthcare journey. Understanding the range of treatment options, including electrodiagnostic studies (EDS), therapeutic modalities, steroid injections, and oral steroids, is crucial. Patients should discuss the potential benefits and risks of each treatment with their healthcare providers and ask about the rationale behind their treatment recommendations. Seeking second opinions and researching the treatment approaches offered by different facilities can also help patients make more informed decisions. The study emphasizes the importance of open communication and shared decision-making between patients and healthcare providers to ensure that treatment aligns with individual needs and preferences. However, the study does not address strategies for navigating insurance coverage or accessing specialized care, which can also influence treatment choices.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.